Quantitative ex vivo detection of rodent retinal ganglion cells by immunolabeling Brn-3b

Kathleen M. Leahy, Richard L. Ornberg, Yu Wang, Yanli Zhu, Jeffrey M. Gidday, Jane R. Connor, Martin B. Wax

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

To evaluate the neuroprotective potential of drug candidates to treat human glaucoma, a short-term rodent model of retinal ganglion cell death was employed. Transient ischemia applied to the rodent retina, with subsequent reperfusion for 1-4 weeks, produces an experimental retinal ganglion cell death that is quantifiable. A widely used method to detect viable retinal ganglion cells involves surgical injection of labeling compounds into the superior colliculus of the rodent brain, the retrograde transport of the compounds along the axons to the retina, and subsequent microscopic evaluation of the retina. In order to circumvent the labor intensive and invasive surgery of this method, we sought an alternative means of assessing retinal ganglion cell survival that would be more suitable for high-throughput analysis. We therefore developed a method of immunolabeling whole retinas ex vivo with an antibody to Brn-3b, an antigen expressed in a subpopulation of retinal ganglion cells, that allows for detection of a representative retinal ganglion cell population. Fluorescently tagged Brn-3b immunolabeled retinas were flat-mounted, digitally imaged, and assessed using image analysis software. We determined that 60 min of ischemia caused a 49% and a 32% decrease in Brn-3b positive retinal ganglion cells in Lewis rats after 4 weeks reperfusion, and Sprague-Dawley rats after 2 weeks reperfusion, respectively. In Swiss Webster ND4 mouse retinas subjected to 45 min ischemia and 7 days reperfusion, we found a 70% decrease in Brn-3b positive cells. Thus, ex vivo immunolabeling of retinal ganglion cells using antibody to Brn-3b provides an alternative to other methods of quantifying retinal ganglion cells.

Original languageEnglish (US)
Pages (from-to)131-140
Number of pages10
JournalExperimental Eye Research
Volume79
Issue number1
DOIs
StatePublished - Jul 2004

Fingerprint

Retinal Ganglion Cells
Rodentia
Retina
Reperfusion
Ischemia
Cell Death
Superior Colliculi
Antibodies
Neuroprotective Agents
Glaucoma
Sprague Dawley Rats
Axons
Cell Survival
Software
Antigens
Injections
Brain

Keywords

  • alternative
  • Brn-3b
  • glaucoma
  • immunolabeling
  • ischemia
  • neurons
  • retina
  • retinal ganglion cells
  • retrograde

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Leahy, K. M., Ornberg, R. L., Wang, Y., Zhu, Y., Gidday, J. M., Connor, J. R., & Wax, M. B. (2004). Quantitative ex vivo detection of rodent retinal ganglion cells by immunolabeling Brn-3b. Experimental Eye Research, 79(1), 131-140. https://doi.org/10.1016/j.exer.2004.02.007

Quantitative ex vivo detection of rodent retinal ganglion cells by immunolabeling Brn-3b. / Leahy, Kathleen M.; Ornberg, Richard L.; Wang, Yu; Zhu, Yanli; Gidday, Jeffrey M.; Connor, Jane R.; Wax, Martin B.

In: Experimental Eye Research, Vol. 79, No. 1, 07.2004, p. 131-140.

Research output: Contribution to journalArticle

Leahy, KM, Ornberg, RL, Wang, Y, Zhu, Y, Gidday, JM, Connor, JR & Wax, MB 2004, 'Quantitative ex vivo detection of rodent retinal ganglion cells by immunolabeling Brn-3b', Experimental Eye Research, vol. 79, no. 1, pp. 131-140. https://doi.org/10.1016/j.exer.2004.02.007
Leahy, Kathleen M. ; Ornberg, Richard L. ; Wang, Yu ; Zhu, Yanli ; Gidday, Jeffrey M. ; Connor, Jane R. ; Wax, Martin B. / Quantitative ex vivo detection of rodent retinal ganglion cells by immunolabeling Brn-3b. In: Experimental Eye Research. 2004 ; Vol. 79, No. 1. pp. 131-140.
@article{be07903fb6b54d9fa6dab99b6656df36,
title = "Quantitative ex vivo detection of rodent retinal ganglion cells by immunolabeling Brn-3b",
abstract = "To evaluate the neuroprotective potential of drug candidates to treat human glaucoma, a short-term rodent model of retinal ganglion cell death was employed. Transient ischemia applied to the rodent retina, with subsequent reperfusion for 1-4 weeks, produces an experimental retinal ganglion cell death that is quantifiable. A widely used method to detect viable retinal ganglion cells involves surgical injection of labeling compounds into the superior colliculus of the rodent brain, the retrograde transport of the compounds along the axons to the retina, and subsequent microscopic evaluation of the retina. In order to circumvent the labor intensive and invasive surgery of this method, we sought an alternative means of assessing retinal ganglion cell survival that would be more suitable for high-throughput analysis. We therefore developed a method of immunolabeling whole retinas ex vivo with an antibody to Brn-3b, an antigen expressed in a subpopulation of retinal ganglion cells, that allows for detection of a representative retinal ganglion cell population. Fluorescently tagged Brn-3b immunolabeled retinas were flat-mounted, digitally imaged, and assessed using image analysis software. We determined that 60 min of ischemia caused a 49{\%} and a 32{\%} decrease in Brn-3b positive retinal ganglion cells in Lewis rats after 4 weeks reperfusion, and Sprague-Dawley rats after 2 weeks reperfusion, respectively. In Swiss Webster ND4 mouse retinas subjected to 45 min ischemia and 7 days reperfusion, we found a 70{\%} decrease in Brn-3b positive cells. Thus, ex vivo immunolabeling of retinal ganglion cells using antibody to Brn-3b provides an alternative to other methods of quantifying retinal ganglion cells.",
keywords = "alternative, Brn-3b, glaucoma, immunolabeling, ischemia, neurons, retina, retinal ganglion cells, retrograde",
author = "Leahy, {Kathleen M.} and Ornberg, {Richard L.} and Yu Wang and Yanli Zhu and Gidday, {Jeffrey M.} and Connor, {Jane R.} and Wax, {Martin B.}",
year = "2004",
month = "7",
doi = "10.1016/j.exer.2004.02.007",
language = "English (US)",
volume = "79",
pages = "131--140",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Quantitative ex vivo detection of rodent retinal ganglion cells by immunolabeling Brn-3b

AU - Leahy, Kathleen M.

AU - Ornberg, Richard L.

AU - Wang, Yu

AU - Zhu, Yanli

AU - Gidday, Jeffrey M.

AU - Connor, Jane R.

AU - Wax, Martin B.

PY - 2004/7

Y1 - 2004/7

N2 - To evaluate the neuroprotective potential of drug candidates to treat human glaucoma, a short-term rodent model of retinal ganglion cell death was employed. Transient ischemia applied to the rodent retina, with subsequent reperfusion for 1-4 weeks, produces an experimental retinal ganglion cell death that is quantifiable. A widely used method to detect viable retinal ganglion cells involves surgical injection of labeling compounds into the superior colliculus of the rodent brain, the retrograde transport of the compounds along the axons to the retina, and subsequent microscopic evaluation of the retina. In order to circumvent the labor intensive and invasive surgery of this method, we sought an alternative means of assessing retinal ganglion cell survival that would be more suitable for high-throughput analysis. We therefore developed a method of immunolabeling whole retinas ex vivo with an antibody to Brn-3b, an antigen expressed in a subpopulation of retinal ganglion cells, that allows for detection of a representative retinal ganglion cell population. Fluorescently tagged Brn-3b immunolabeled retinas were flat-mounted, digitally imaged, and assessed using image analysis software. We determined that 60 min of ischemia caused a 49% and a 32% decrease in Brn-3b positive retinal ganglion cells in Lewis rats after 4 weeks reperfusion, and Sprague-Dawley rats after 2 weeks reperfusion, respectively. In Swiss Webster ND4 mouse retinas subjected to 45 min ischemia and 7 days reperfusion, we found a 70% decrease in Brn-3b positive cells. Thus, ex vivo immunolabeling of retinal ganglion cells using antibody to Brn-3b provides an alternative to other methods of quantifying retinal ganglion cells.

AB - To evaluate the neuroprotective potential of drug candidates to treat human glaucoma, a short-term rodent model of retinal ganglion cell death was employed. Transient ischemia applied to the rodent retina, with subsequent reperfusion for 1-4 weeks, produces an experimental retinal ganglion cell death that is quantifiable. A widely used method to detect viable retinal ganglion cells involves surgical injection of labeling compounds into the superior colliculus of the rodent brain, the retrograde transport of the compounds along the axons to the retina, and subsequent microscopic evaluation of the retina. In order to circumvent the labor intensive and invasive surgery of this method, we sought an alternative means of assessing retinal ganglion cell survival that would be more suitable for high-throughput analysis. We therefore developed a method of immunolabeling whole retinas ex vivo with an antibody to Brn-3b, an antigen expressed in a subpopulation of retinal ganglion cells, that allows for detection of a representative retinal ganglion cell population. Fluorescently tagged Brn-3b immunolabeled retinas were flat-mounted, digitally imaged, and assessed using image analysis software. We determined that 60 min of ischemia caused a 49% and a 32% decrease in Brn-3b positive retinal ganglion cells in Lewis rats after 4 weeks reperfusion, and Sprague-Dawley rats after 2 weeks reperfusion, respectively. In Swiss Webster ND4 mouse retinas subjected to 45 min ischemia and 7 days reperfusion, we found a 70% decrease in Brn-3b positive cells. Thus, ex vivo immunolabeling of retinal ganglion cells using antibody to Brn-3b provides an alternative to other methods of quantifying retinal ganglion cells.

KW - alternative

KW - Brn-3b

KW - glaucoma

KW - immunolabeling

KW - ischemia

KW - neurons

KW - retina

KW - retinal ganglion cells

KW - retrograde

UR - http://www.scopus.com/inward/record.url?scp=2942536160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942536160&partnerID=8YFLogxK

U2 - 10.1016/j.exer.2004.02.007

DO - 10.1016/j.exer.2004.02.007

M3 - Article

C2 - 15183108

AN - SCOPUS:2942536160

VL - 79

SP - 131

EP - 140

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

IS - 1

ER -